Main Business：专注创新、高风险、植（介）入医疗器械临床试验的CRO公司，为企业在医疗器械研发过程中提供全过程、一站式的临床试验解决方案。Company Type：Components Supplier
Size：1-49人
Capital：516.13万RMB
Establishment：2017
Sell：专注创新、高风险、植（介）入医疗器械临床试验的CRO公司，为企业在医疗器械研发过程中提供全过程、一站式的临床试验解决方案。
Lingshi Medical Technology (Shanghai) Co., Ltd. (trading as LINKS CRO) is a CRO enterprise focusing on clinical trials of innovative, high-risk interventional and implantable medical devices. We deliver full-lifecycle, one-stop clinical trial solutions throughout the medical device R&D process.
LINKS stands for connection, which embodies the core philosophy of Lingshi Medical. We act as a bridge linking sponsors, research institutions and investigators. Supported by a comprehensive service system and leading quality standards, we provide professional services to help clients boost R&D efficiency, mitigate registration risks, ensure high-quality delivery of research projects and accelerate products’ time-to-market.
Core Service Scope
Clinical evaluation strategy consultation, CRO services, CER preparation, audit services, post-market clinical studies, domestic & overseas registration, central laboratory testing, innovative medical device filing, NMPA hearing coaching, and overseas enterprise authorized agent services.
Covered Therapeutic Areas
Cardiology, neurovascular intervention, peripheral vascular intervention, surgical systems, oncology, ophthalmology, medical aesthetics, orthopedics and other disciplines. We provide consultation and consulting support for nearly 300 projects annually.